The Pacemaker podcast

Kevin Kalish: Circulating the Cerebrospinal Fluid for Drug Delivery with Enclear Therapies

0:00
57:36
Spol 15 sekunder tilbage
Spol 15 sekunder frem
Kevin Kalish is the COO of Enclear Therapies, a biotechnology company that has developed a novel platform for delivering therapeutics to hard-to-reach areas of the central nervous system by circulating the Cerebrospinal Fluid. Enclear's innovative technology holds promise as a means to treat a variety of neuro-oncological and neurodegenerative diseases. In this conversation with Kevin, we discuss the technology, its initial indications, its promises, and the challenges that must be overcome to get there.

Flere episoder fra "The Pacemaker"